Mayne Pharma Group ( (AU:MYX) ) has issued an update.
UBS Group AG and its related bodies corporate have reduced their voting power in Mayne Pharma Group Limited from 9.02% to 7.47% as of March 10, 2025. This change in substantial holding may impact the company’s shareholder dynamics and influence its future strategic decisions, potentially affecting stakeholders’ interests.
More about Mayne Pharma Group
YTD Price Performance: 53.12%
Average Trading Volume: 2,110
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $369.5M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com